Oakley's new lens offerings combine the technologies of Transitions V with ESP(r) photochromic technology, Oakley Iridium lens coating and Oakley Plutonite(r) lens material. The partnership with Transitions marks the first time that photochromics have been integrated with Oakley prescription optics. Transitions' photochromic technology makes lenses darken automatically in response to sunlight.
“This partnership offers a valuable opportunity we expect will further extend Oakley's growing business in prescription eyewear,” said Oakley President Colin Baden. “By combining the proven technologies of both companies, we are able to offer a world first: prescription lenses that blend Oakley's world-class lens material and lens coatings with the breakthroughs of Transitions photochromic technology.”
“The Oakley brand is well-known, and is associated with innovation and quality, so we see this as an excellent opportunity to complement Transitions' industry leadership and continue our commitment to growing the photochromics category,” said Dave Cole, general manager of the Americas, Transitions Optical. “Oakley and Transitions are both dedicated to achieving eyewear innovations that protect, enhance and promote healthy sight, so this is a natural partnership that enables us to build on our widespread ability to provide even more choices in prescription lenses.”
